Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Open in API
Filings indexed 1,548 across all filing types
Latest filing 2024-02-09 Regulatory Filings
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 100% confidence The document is a formal submission to stock exchanges (BSE and NSE) reporting a violation related to the company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015. It includes details of the designated person involved, the nature of the violation, actions taken by the company, and compliance with SEBI circular requirements. The document is not a financial report, earnings release, or management discussion but a regulatory compliance filing reporting insider trading violations. It does not contain financial statements or management analysis but is a regulatory announcement of a compliance issue. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-02-09 English
Bodal Chemicals Ltd has informed exchange about schedule of Earning Call
Regulatory Filings
2024-02-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a notification about an upcoming earnings call for Q3 & 9M FY24, including details on the date, time, dial-in numbers, and participants. It does not contain actual financial results or substantive financial data but rather serves as an invitation and announcement for the conference call. The document length is 4133 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this is not the earnings release itself nor the call transcript but an announcement of the earnings call event. According to the filing definitions, this fits best under Call Transcript (CT) only if it contained the full transcript, which it does not. It is also not a Regulatory Filing (RNS) because it is a formal announcement of an event. The best fit is Call Transcript (CT) if the transcript was included, but since this is only an invitation, the closest category is Regulatory Filings (RNS) as a general announcement. However, given the options and the nature of the document, the most appropriate classification is Call Transcript (CT) with low confidence because it is related to the earnings call but does not contain the transcript itself. Alternatively, it could be considered a Regulatory Filing (RNS). Given the instructions, the document is an announcement of the earnings call, so the best classification is Regulatory Filings (RNS).
2024-02-06 English
Board Meeting — BODAL CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for t…
Regulatory Filings
2024-02-06 English
Board Meeting — Financial Results/Other business matters
Board/Management Information Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board Meeting scheduled for February 13, 2024. The agenda includes consideration and approval of unaudited financial results for the quarter and nine months ended December 31, 2023. It also mentions compliance with insider trading regulations and trading window closure. The document does not contain actual financial data or results but is an announcement of a future event related to management and board activities. Therefore, it is best classified as a Board/Management Information filing, which covers announcements of board meetings and related management information.
2024-02-06 English
BODAL CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve Standalone and Consolidated ....
Regulatory Filings
2024-02-06 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.